Smoking effects on renal function in young men with early stages of essential arterial hypertension
Abstract
Aim. To study smoking effects on renal damage progression in young men with early stages of essential arterial hypertension (AH).
Material and methods. The study included 118 AH men aged 18–35 years (mean age 22,1±4,54 years). AH duration varied from 1 to 8 years (mean duration 4,14±2,1 years). Self-reported smoking prevalence (>1 cigarette per day) was 52 % (n=61). Smokers and non-smokers were comparable by age, AH duration, body mass index, and other cardiovascular risk factors. All participants underwent dynamic renal angioscintigraphy, with intravenous Tc99m DTPA administration and glomerular filtration rate (GFR) assessment.
Results. According to dynamic renal angioscintigraphy data, GFR levels differed significantly in smokers and non-smokers with Stage I AH. In Stage II and III AH, the difference was not statistically significant.
Conclusion. Smoking facilitated hyperfiltration progression in Stage I AH young men, comparing to non-smoking patients.
About the Authors
T. A. Dyakova
I.M. Sechenov Moscow Medical Academy, City Clinical Hospital No. 61, Moscow
Russian Federation
Russian Federation
I. G. Fomina
I.M. Sechenov Moscow Medical Academy, City Clinical Hospital No. 61, Moscow
Russian Federation
Russian Federation
N. E. Gaidamakina
I.M. Sechenov Moscow Medical Academy, City Clinical Hospital No. 61, Moscow
Russian Federation
Russian Federation
References
1. Л.И. Гапон, Г. Н. Веселина, С. Н. Колесникова, А. А. Прилепова Оценка влияния атенолола и нифедипина ретард на функциональное состояние мозгового кровообращения у больных артериальной гипертонией в зависимости от факторов риска. Артер гиперт 2003; 9(5): 34–42.
2. Г. Я. Масленникова, Р. Г. Оганов Влияние курения на здоровье населения: место России в Европе. Профил забол укреп здор 2002; 6: 17–20, 29.
3. С. А. Шальнова, А. Д. Деев, Р. Г. Оганов Распространенность курения в России. Результаты обследования национальной представительной выборки населения. Профил забол укреп здор 1998; 3: 54–62.
4. Б. И. Шулутко Артериальная гипертензия 2000. Санкт-Петербург «РЕНКОР» 2001; 382 с.
5. Bleyer AJ, Shemanski LR, Burke JL, et al. Tobacco, hypertension, and vascular disease. Kidney Int 2000; 57: 2072–9.
6. Celemajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150–4.
7. Folkow B. The pathophysiology of hypertension. Drugs 1993; 46(Suppl. 2): 3–7.
8. Gerstein HC, Mann JF, Pogue J, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the heart outcomes prevention evaluation study. The HOPE study investigators. Diabetes Care 2000; 23(Suppl 2): B35–9.
9. Halimi JM, Giraudeau B, Vol S, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 2000; 58: 1285–92.
10. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13–8.
11. Mancia G. Manual of Hypertension. London, Churchill Livingstone 2002; 706.
12. Ono H, Ono Y: Nephrosclerosis and hypertension. Med Clin North Am 1997; 81(6): 1273–88.
13. Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002; 13: 1663–72.
14. Schmieder RE, Veelken R, Jatjra CD, et. al. Predictors for hypertensive nephropaty: results of a 6-year follow-up study in essential hypertension. J Hypertension 1994; 13: 357–65.
15. Verdecchia P, Schillacci G, Borgioni C, et al. Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension. J Hypertens 1995; 13: 1209–15.
16. Zillich AJ, Saseen JJ, DeHart RM, et al. Caring for Patients With Chronic Kidney Disease: A Joint Opinion of the Ambulatory Care and the Nephrology Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy 2005; 25(1): 123–43.
Review
For citations:
Dyakova T.A., Fomina I.G., Gaidamakina N.E. Smoking effects on renal function in young men with early stages of essential arterial hypertension. Cardiovascular Therapy and Prevention. 2007;7(7):13-15. (In Russ.)
Views:
5016
Email this article 
